Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revii AI is a clinical trial intelligence company that leverages artificial intelligence to optimize the design and execution of clinical trials. The company's platform integrates diverse biomedical data sources to provide actionable insights for protocol optimization, patient stratification, and risk mitigation. By enhancing the efficiency and predictability of clinical research, Revii AI helps pharmaceutical and biotechnology companies reduce development timelines and improve the likelihood of regulatory approval. The platform is specifically designed to address high failure rates in clinical development by identifying the most promising trial parameters and patient populations through advanced data analytics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revii AI.